BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3793932)

  • 1. Complementation analysis of fatty acid oxidation disorders.
    Moon A; Rhead WJ
    J Clin Invest; 1987 Jan; 79(1):59-64. PubMed ID: 3793932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies.
    Gregersen N
    Scand J Clin Lab Invest Suppl; 1985; 174():1-60. PubMed ID: 3892650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
    Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L
    Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
    Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
    Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts.
    Amendt BA; Rhead WJ
    J Clin Invest; 1986 Jul; 78(1):205-13. PubMed ID: 3722376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defect in fatty acid oxidation: laboratory and pathologic findings in a patient.
    Tonsgard JH; Stephens JK; Rhead WJ; Penn D; Horwitz AL; Kirschner BS; Whitington PF; Berger S; Tripp ME
    Pediatr Neurol; 1991; 7(2):125-30. PubMed ID: 2059253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical characterization of variant long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase deficiency.
    Indo Y; Coates PM; Hale DE; Tanaka K
    Pediatr Res; 1991 Sep; 30(3):211-5. PubMed ID: 1945557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
    Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
    Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
    Tucci S; Behringer S; Spiekerkoetter U
    FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.
    Vianey-Saban C; Divry P; Brivet M; Nada M; Zabot MT; Mathieu M; Roe C
    Clin Chim Acta; 1998 Jan; 269(1):43-62. PubMed ID: 9498103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic defect of medium-chain acyl-coenzyme A dehydrogenase deficiency. Lack of both cofactor responsiveness and biochemical heterogeneity in eight patients.
    Amendt BA; Rhead WJ
    J Clin Invest; 1985 Sep; 76(3):963-9. PubMed ID: 3840178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical characterization of variant medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Coates PM; Indo Y; Young D; Hale DE; Tanaka K
    Pediatr Res; 1992 Jan; 31(1):34-8. PubMed ID: 1594327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
    Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
    Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
    He M; Rutledge SL; Kelly DR; Palmer CA; Murdoch G; Majumder N; Nicholls RD; Pei Z; Watkins PA; Vockley J
    Am J Hum Genet; 2007 Jul; 81(1):87-103. PubMed ID: 17564966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
    Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
    J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deficiency of medium-chain acyl coenzyme A dehydrogenase: studies in cultured skin fibroblasts and peripheral mononuclear leukocytes.
    Coates PM; Hale DE; Stanley CA; Corkey BE; Cortner JA
    Pediatr Res; 1985 Jul; 19(7):671-6. PubMed ID: 4022673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-chain acyl-CoA profiles in cultured fibroblasts from patients with defects in fatty acid oxidation.
    Tamvakopoulos CS; Willi S; Anderson VE; Hale DE
    Biochem Mol Med; 1995 Jun; 55(1):15-21. PubMed ID: 7551821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.